Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2457
  • Dowloads 145

Reviews

Open Access

Mesonephric-like carcinoma of the uterine corpus: A case report and literature review

  • Hyang Sook Jeong1
  • Yuki Gen2
  • Hui Ryun Joo2
  • Ji Geun Yoo3
  • Seung Geun Yeo4
  • Dong Choon Park2,*,

1Department of Hospital Pathology, St. Vincent’s Hospital, The Catholic University of Korea, Seoul, South Korea

2Department of Obstetrics and Gynecology, St. Vincent’s Hospital, The Catholic University of Korea, Seoul, South Korea

3Department of Obstetrics and Gynecology, Daejeon St, Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea

4Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University, Seoul, South Korea

DOI: 10.31083/j.ejgo.2020.05.5420 Vol.41,Issue 5,October 2020 pp.664-667

Submitted: 29 October 2019 Accepted: 27 April 2020

Published: 15 October 2020

*Corresponding Author(s): Dong Choon Park E-mail: park.dongchoon@gmail.com

PDF (3.7 MB) View Full-text

Abstract

This report describes a woman with uterine mesonephric-like carcinoma and reviews the literature on this rare condition. A 60-year-old woman was referred for abdominal discomfort. Pelvic magnetic resonance imaging showed a tumor, about 7.0 cm in diameter in her left ovary. Surgical exploration, however, showed that both ovaries were grossly free of tumor. Rather, a protruding cancerous mass was found on the left side of her uterus. The tumor was composed of cells with various growth patterns and was diffusely positive for PAX8 and GATA3 on immunohistochemistry. The apical luminal border of the glandular structures was positive for CD10, and the glandular structures were focally positive for EMA. The final diagnosis was mesonephric-like carcinoma, stage pT3N1M. Conclusion: Diagnosing mesonephric-like carcinoma is pathologically challenging because these tumors are rare and present with a wide spectrum of morphologic patterns. Positive staining for PAX8 and GATA3 and a luminal staining pattern of CD10 can support the diagnosis.


Keywords

Mesonephric-like carcinoma; Uterine corpus; Immunohistochemistry.


Cite and Share

Hyang Sook Jeong,Yuki Gen,Hui Ryun Joo,Ji Geun Yoo,Seung Geun Yeo,Dong Choon Park. Mesonephric-like carcinoma of the uterine corpus: A case report and literature review. European Journal of Gynaecological Oncology. 2020. 41(5);664-667.

URL:

https://www.ejgo.net/articles/10.31083/j.ejgo.2020.05.5420

References

[1] Marquette A., Moerman P., Vergote I., Amant F.: “Second case of uterine mesonephric adenocarcinoma”. Int. J. Gynecol. Cancer, 2006, 16, 1450-1454.

[2] Ferry J.A., Scully R.E.: “Mesonephric Remnants, Hyperplasia, and Neoplasia in the Uterine Cervix”. Am. J. Surg. Pathol., 1990, 14, 1100-1111.

[3] Bagué S., Rodríguez I.M., Prat J.: “Malignant Mesonephric Tumors of the Female Genital Tract”. Am. J. Surg. Pathol., 2004, 28, 601-607.

[4] Wu H., Zhang L., Cao W., Hu Y., Liu Y.: “Mesonephric adenocar-cinoma of the uterine corpus”. Int. J. Clin. Exp. Pathol., 2015, 7, 7012-7019.

[5] Zhang L., Cai Z., Ambelil M., Conyers J., Zhu H.: “Mesonephric Adenocarcinoma of the Uterine Corpus”. Int. J. Gynecol. Pathol., 2019, 38, 224-229.

[6] Yamamoto Y., Akagi A., Izumi K., Kishi Y.: “Carcinosarcoma of the uterine body of mesonephric origin”. Pathol. Int., 1995, 45, 303-309.

[7] Ordi J., Nogales F.F., Palacin A., Márquez M., Pahisa J., Vanrell J. A., et al.: “Mesonephric Adenocarcinoma of the Uterine Corpus”. Am. J. Surg. Pathol., 2001, 25, 1540-1545.

[8] Ando H., Watanabe Y., Ogawa M., Tamura H., Deguchi T., Ikeda K., et al.: “Mesonephric adenocarcinoma of the uterine corpus with intracystic growth completely confined to the myometrium: a case report and literature review”. Diagn. Pathol., 2017, 12, 63.

[9] Na K., Kim H.: “Clinicopathologic and Molecular Characteristics of Mesonephric Adenocarcinoma Arising From the Uterine Body”. Am. J. Surg. Pathol., 2019, 43, 12-25.

[10] Kim S.S., Nam J.H., Kim G., Choi Y.D., Choi C., Park C.S.: “Mesonephric Adenocarcinoma of the Uterine Corpus”. Int. J. Gynecol. Pathol., 2016, 24, 153-158.

[11] Silver S.A., Devouassoux-Shisheboran M., Mezzetti T.P., Tavassoli F. A.: “Mesonephric Adenocarcinomas of the Uterine Cervix”. Am.J. Surg. Pathol., 2001, 25, 379-387.

[12] Pors J., Cheng A., Leo J.M., Kinloch M.A., Gilks B., Hoang L.: “A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract”. Am. J. Surg. Pathol., 2018, 42, 1596-1606.

[13] Clement P.B., Young R.H., Keh P., Östör A.G., Scully R.E.: “A Report of Eight Cases, Including Four with a Malignant Spindle Cell Component”. Am. J. Surg. Pathol., 1995, 19, 1158-1171.

[14] Howitt B.E., Emori M.M., Drapkin R., Gaspar C., Barletta J.A., Nucci M.R., et al.: “GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract”. Am. J. Surg. Pathol., 2015, 39, 1411-1419.

[15] Bifulco G., Mandato V.D., Mignogna C., Giampaolino P., Di Spiezio Sardo A., De Cecio R., et al.: “A case of mesonephric adenocarcinoma of the vagina with a 1-year follow-up”. Int. J. Gynecol. Cancer, 2008, 18, 1127-1131.

[16] Mueller I., Kametriser G., Jacobs V.R., Bogner G., Staudach A., Koch H., et al.: “Mesonephric adenocarcinoma of the vagina”. Strahlenther. Onkol., 2016, 192, 668-671.


Submission Turnaround Time

Top